American Century Companies’s Contineum Therapeutics CTNM Stock Holding History

American Century Companies's CTNM Position: Q2 2026 in Review

American Century Companies increased its Contineum Therapeutics (CTNM) stake by 42% in Q2 2026, buying an estimated $194K and bringing the position to 50,513 shares worth $828K. The position accounts for ﹤0.01% of the portfolio, ranked #2459.

American Century Companies first reported a position in CTNM in Q4 2025 and has held it in 3 quarters since. 47 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

• American Century Companies held 50,513 shares of Contineum Therapeutics worth $828K as of Q2 2026.
• American Century Companies bought 14,832 Contineum Therapeutics shares in Q2 2026, an estimated $194K.
• Contineum Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2459 holding.
• American Century Companies first reported a position in Contineum Therapeutics in Q4 2025 and has held it in 3 quarters since.
• 47 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.